Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.87%
|
$7,000
$7.03 P/Share
|
|
May 26
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
19,687
-1.45%
|
$295,305
$15.77 P/Share
|
|
May 25
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
30,313
-2.19%
|
$454,695
$15.35 P/Share
|
|
May 18
2022
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,200
+18.05%
|
$93,000
$15.8 P/Share
|
|
May 17
2022
|
John K Bakewell |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
|
May 17
2022
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
|
May 17
2022
|
Deepti Jain |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+44.86%
|
-
|
|
May 17
2022
|
Richard W Mott |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+0.14%
|
-
|
|
May 17
2022
|
Thomas E Timbie Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
|
May 17
2022
|
Betsy Hanna |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+44.86%
|
-
|
|
May 09
2022
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
120,000
-23.76%
|
-
|
|
May 09
2022
|
John R Treace Director |
SELL
Open market or private sale
|
Indirect |
75,000
-1.0%
|
$1,050,000
$14.67 P/Share
|
|
May 09
2022
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
1,000
-8.55%
|
$15,000
$15.96 P/Share
|
|
May 09
2022
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.87%
|
$7,000
$7.03 P/Share
|
|
Mar 10
2022
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
2
-100.0%
|
$38
$19.2 P/Share
|
|
Mar 10
2022
|
Richard W Mott |
SELL
Bona fide gift
|
Direct |
105,000
-6.18%
|
-
|
|
Mar 08
2022
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+18.25%
|
-
|
|
Mar 08
2022
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
11,950
+50.0%
|
-
|
|
Mar 08
2022
|
Jaime A. Frias Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,875
+13.45%
|
-
|
|
Mar 08
2022
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,950
+35.25%
|
-
|
|
Mar 08
2022
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,875
+0.62%
|
-
|
|
Mar 08
2022
|
Terry W. Lubben SVP, Operations |
BUY
Open market or private purchase
|
Direct |
2,500
+29.94%
|
$45,000
$18.62 P/Share
|
|
Mar 08
2022
|
Terry W. Lubben SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,350
+50.0%
|
-
|
|
Mar 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,575
+50.0%
|
-
|
|
Mar 08
2022
|
Daniel E. Owens |
BUY
Grant, award, or other acquisition
|
Direct |
6,700
+38.51%
|
-
|
|
Mar 02
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$500,000
$20.82 P/Share
|
|
Mar 02
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.05 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
3,873
-100.0%
|
$77,460
$20.16 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,873
+50.0%
|
$3,873
$1.05 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
21,127
-100.0%
|
$422,540
$20.02 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,127
+50.0%
|
$21,127
$1.05 P/Share
|
|
Feb 04
2022
|
James T Treace |
SELL
Bona fide gift
|
Indirect |
450,000
-44.72%
|
-
|
|
Jan 19
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
32,063
-2.26%
|
$577,134
$18.99 P/Share
|
|
Jan 18
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
42,937
-1.47%
|
$815,803
$19.68 P/Share
|
|
Jan 13
2022
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
95,000
-15.83%
|
-
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
8,838
-100.0%
|
$176,760
$20.12 P/Share
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,838
+46.03%
|
$8,838
$1.31 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
38,862
-100.0%
|
$777,240
$20.16 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,862
+47.04%
|
$38,862
$1.57 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
800
-100.0%
|
$16,000
$20.02 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+50.0%
|
$800
$1.57 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$10,000
$20.0 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$500
$1.57 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$20,000
$20.02 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$1,000
$1.57 P/Share
|
|
Dec 29
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,075
-0.06%
|
$52,275
$17.01 P/Share
|
|
Dec 28
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
1,563
-99.87%
|
$25,008
$16.88 P/Share
|
|
Dec 28
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,760
-0.36%
|
$316,160
$16.99 P/Share
|
|
Dec 27
2021
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
6,437
-80.44%
|
$109,429
$17.46 P/Share
|
|
Dec 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,165
-0.31%
|
$291,805
$17.44 P/Share
|